BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23557861)

  • 1. The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K).
    Ambardekar VV; Wakaskar RR; Sharma B; Bowman J; Vayaboury W; Singh RK; Vetro JA
    Biomaterials; 2013 Jul; 34(20):4839-48. PubMed ID: 23557861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration.
    Ambardekar VV; Wakaskar RR; Ye Z; Curran SM; McGuire TR; Coulter DW; Singh RK; Vetro JA
    Int J Pharm; 2018 May; 543(1-2):130-138. PubMed ID: 29601972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modification of siRNA with 3' cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes.
    Ambardekar VV; Han HY; Varney ML; Vinogradov SV; Singh RK; Vetro JA
    Biomaterials; 2011 Feb; 32(5):1404-11. PubMed ID: 21047680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer.
    Ye Z; Abdelmoaty MM; Ambardekar VV; Curran SM; Dyavar SR; Arnold LL; Cohen SM; Kumar D; Alnouti Y; Coulter DW; Singh RK; Vetro JA
    Nanomedicine; 2021 Apr; 33():102363. PubMed ID: 33545405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC.
    Ye Z; Abdelmoaty MM; Curran SM; Dyavar SR; Kumar D; Alnouti Y; Coulter DW; Podany AT; Singh RK; Vetro JA
    Noncoding RNA; 2022 Jan; 8(1):. PubMed ID: 35076584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA.
    Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A
    J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
    Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
    Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection.
    Fu C; Sun X; Liu D; Chen Z; Lu Z; Zhang N
    Int J Mol Sci; 2011 Feb; 12(2):1371-88. PubMed ID: 21541064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymer structure on micelles formed between siRNA and cationic block copolymer comprising thiols and amidines.
    Christie RJ; Miyata K; Matsumoto Y; Nomoto T; Menasco D; Lai TC; Pennisi M; Osada K; Fukushima S; Nishiyama N; Yamasaki Y; Kataoka K
    Biomacromolecules; 2011 Sep; 12(9):3174-85. PubMed ID: 21863796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA.
    Choi YH; Liu F; Choi JS; Kim SW; Park JS
    Hum Gene Ther; 1999 Nov; 10(16):2657-65. PubMed ID: 10566893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery.
    Li J; Cheng D; Yin T; Chen W; Lin Y; Chen J; Li R; Shuai X
    Nanoscale; 2014; 6(3):1732-40. PubMed ID: 24346086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyethylene glycol-poly(ε-benzyloxycarbonyl-l-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma.
    Wang G; Gao X; Gu G; Shao Z; Li M; Wang P; Yang J; Cai X; Li Y
    Int J Nanomedicine; 2017; 12():3591-3603. PubMed ID: 28533682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
    Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
    ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer nanoassemblies with hydrophobic pendant groups in the core induce false positive siRNA transfection in luciferase reporter assays.
    Rheiner S; Reichel D; Rychahou P; Izumi T; Yang HS; Bae Y
    Int J Pharm; 2017 Aug; 528(1-2):536-546. PubMed ID: 28629980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors.
    Oe Y; Christie RJ; Naito M; Low SA; Fukushima S; Toh K; Miura Y; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    Biomaterials; 2014 Sep; 35(27):7887-95. PubMed ID: 24930854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles.
    Kim HJ; Takemoto H; Yi Y; Zheng M; Maeda Y; Chaya H; Hayashi K; Mi P; Pittella F; Christie RJ; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    ACS Nano; 2014 Sep; 8(9):8979-91. PubMed ID: 25133608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-polymer conjugation to fabricate multi-block polymer as novel drug carriers: poly(lactic acid)-poly(ethylene glycol)-poly(L-lysine) to enhance paclitaxel target delivery.
    Liu Y; Liu C; Li M; Liu F; Feng L; Zhang L; Zhang N
    J Biomed Nanotechnol; 2014 Jun; 10(6):948-58. PubMed ID: 24749390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate.
    Meyer M; Dohmen C; Philipp A; Kiener D; Maiwald G; Scheu C; Ogris M; Wagner E
    Mol Pharm; 2009; 6(3):752-62. PubMed ID: 19348503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-
    Xu G; Gu H; Hu B; Tong F; Liu D; Yu X; Zheng Y; Gu J
    Int J Nanomedicine; 2017; 12():2243-2254. PubMed ID: 28356740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.